Recreational drug toxicity [PDF]
Clinical Medicine, 2008 Simon, Hill, Simon H L, Thomas
openaire +2 more sources
Network and Pathway Analysis of Toxicogenomics Data
Frontiers in Genetics, 2018 Toxicogenomics is the study of the molecular effects of chemical, biological and physical agents in biological systems, with the aim of elucidating toxicological mechanisms, building predictive models and improving diagnostics.
Gal Barel, Ralf Herwig
doaj +1 more source
Separating host and microbiome contributions to drug pharmacokinetics and toxicity
Science, 2019 Off-target drug metabolism Anything humans swallow is exposed to the foraging and transforming activities of the gut microbiota. This applies to therapeutic drugs as well as food components and can be a major source of interpersonal variation in drug ...
Michael Zimmermann +3 more
semanticscholar +1 more source
Acetylcholine-induced reversal of canine and feline atrial myocardial depression during stretch, cardiac failure, and drug toxicity. [PDF]
, 1975 Henry Gelband +3 more
openalex +1 more source
Reducing Toxicity of Immune Therapy Using Aptamer-Targeted Drug Delivery [PDF]
, 2015 Eli Gilboa +2 more
openalex +1 more source
Antioxidant and anti-Inflammation Potentials of Moringa oleifera Aqueous Extract Against breast cancer chemotherapy drug Induced Kidney and Liver Toxicity in Experimental Rats [PDF]
, 2021 A. ESSAWY +4 more
openalex +1 more source
Study of Acute Toxicity of a New Veterinary Drug for Inttrammary Introduction [PDF]
, 2018 Preclinical studies of veterinary medicinal products are important and compulsory studies in the development of new dosage forms. The aim of preclinical research is to determine the toxic effect and therapeutic efficacy of the test substance-the future ...
Polova, Z. (Zhanna)
core
Trabectedin for L-Type Sarcoma: A Retrospective Multicenter Study
Current Oncology(1) Background: Metastatic L-type sarcomas (liposarcoma and leiomyosarcoma) are rare and have a poor prognosis. Trabectedin is an effective agent that can be used after anthracyclines.
Sercan Ön +15 more
doaj +1 more source
Optimized Treatment Schedules for Chronic Myeloid Leukemia
, 2016 Over the past decade, several targeted therapies (e.g. imatinib, dasatinib, nilotinib) have been developed to treat Chronic Myeloid Leukemia (CML). Despite an initial response to therapy, drug resistance remains a problem for some CML patients.
Dingli, David +4 more
core +3 more sources